🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCardiovascular OutcomesHas anyone dealt with tirzepatide cardiovascular safety? Page 9

Has anyone dealt with tirzepatide cardiovascular safety?

carlos_SATX Thu, Sep 18, 2025 at 10:20 PM 41 replies 1,657 viewsPage 9 of 9
Dr.NephBHM_UK
Member
456
2,123
Jun 2024
Birmingham, UK
Oct 7, 2025 at 7:55 PM#41

Adding the clinical framing, because it changes how the question reads. The distinction that resolves most of these threads is between what is true on average and what is true for one person. Both are real; they answer different questions and get quoted as if they were the same one.

Last edited: Oct 8, 2025 at 1:55 AM
41 16Dr.CardioMD, EndoResFellow, PharmacoVig_BOS and 38 others
Reply Quote Save Share Report
TirzTom
Senior Member
2,789
9,876
Feb 2024
Florida
Online
Oct 8, 2025 at 3:21 PM#42
Dr.NephBHM_UK said:
The distinction that resolves most of these threads is between what is true on average and what is true for one person.

This matches mine closely enough to be worth saying so out loud. Posting only so the count is not one.

40 15tom_AK, josh_phd_bmore, roxy_nash and 37 others
Reply Quote Save Share Report
mike_mod
Moderator
7,234
19,823
Nov 2023
New York
Online
Oct 9, 2025 at 10:47 AM#43

Moderator note: the sourcing question belongs in the vendor section and has been split out. Report rather than reply if it drifts again.

39 14DoseLogDan, SleepFixSam, PurityPaulOR and 36 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
dave_SLC
Member
345
1,567
Aug 2024
Salt Lake City, UT
Oct 10, 2025 at 6:14 AM#44

Adding the numbers, since they settle part of this. For anyone reading later: the numbers in this thread are worth checking against a primary source before you act on them, including mine. Half the figures circulating in this community trace back to a secondary summary that dropped a qualifier.

38 13FranDenver, Dr.BariatricHTX, LindaRN_retired and 35 others
Reply Quote Save Share Report
steve_okc
Member
489
2,123
Jul 2024
Oklahoma City, OK
Oct 11, 2025 at 1:41 AM#45

One thing that is still open after Dr.NephBHM_UK’s answer:

Was that from a primary source or from a summary of one?

37 12KetoKyle, CanadaChris, ZaraB_AL and 34 others
Reply Quote Save Share Report
1789

Similar Threads

SELECT trial: 20% MACE reduction — mechanistic deep dive7 replies
Semaglutide cardiovascular benefit independent of weight loss11 replies
STEP-HFpEF: semaglutide in heart failure with preserved EF15 replies
GLP-1 and arterial inflammation — hsCRP and IL-6 reduction data18 replies
Lp(a) on GLP-1 agonists — any impact on this risk factor?8 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register